医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

NZMP SureStart™ Shortlisted as a Finalist in the NutraIngredients-Asia Awards

2018年08月29日 AM06:11
このエントリーをはてなブックマークに追加


 

AUCKLAND, New Zealand

Fonterra’s NZMP SureStart™ milk lipid ingredient ‘MFGM Lipid 100’ has been selected as a finalist in the NutraIngredients-Asia awards for Infant Nutrition in Singapore. Fonterra’s consumer brand Anmum™ is the first to take this innovative ingredient to market used in maternal and paediatric products, Anmum™ with Nuelipid™.

The NutraIngredients-Asia awards celebrate innovation in ingredients designed to meet infant health and development needs, with a judging process that assesses factors such as scientific merit, efficacy and innovation. Winners will be announced on Monday September 10.

Fonterra’s NZMP Category Marketing Manager for Paediatrics, Angela Rowan says the finalist announcement is exciting for the company, reinforcing the importance NZMP places on clinical studies to back up innovation, “We are very proud that MFGM Lipid 100 was shortlisted as a finalist, which we believe is due to strong, scientific and clinical studies on the ingredient, supporting brain development and cognition.”

NZMP is the global dairy ingredients brand of Fonterra, recognised globally for a range of ingredient solutions across the life stages. NZMP SureStart™ supplies a range of infant nutrition ingredients worldwide, including MFGM Lipid 100.

Clinical science backs MFGM Lipid 100:

  • Two clinical studies were carried out in China to investigate the effects of providing additional MFGM (milk fat globule membrane) gangliosides (GA) and phospholipids (PL) during pregnancy and in infancy.
  • Both studies looked at the effects of providing MFGM to support cognitive development.
  • Preliminary findings on supplementation with MFGM in healthy infants in the first 12 months of life showed statistically significant improvements in cognitive development.
  • MFGM supplementation improved General Adaptive Behaviour scores based on the development of a combination of functions such as social and motor skills, self-direction, communication and self-care.
  • NZMP SureStart™ MFGM Lipid 100 is a patent protected ingredient (granted in a number of countries).

Breast milk is the ideal source of nutrition for infants. It contains everything a baby needs up to 6-months-of-age to grow and develop in a healthy way and gives children the very best start in life. Breast milk substitutes are recognised by the World Health Organisation as the only safe and nutritious alternative to breast milk for infants whose mothers cannot, or choose not to, breastfeed.

View source version on businesswire.com: https://www.businesswire.com/news/home/20180828005845/en/

CONTACT

For further information or to organise an interview contact:
Porter
Novelli on behalf of NZMP
Sophie Coley, +64-22-565-8919
sophiec@porternovelli.kiwi

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • アルヴォテックと富士製薬が日本でバイオシミラーを開発・商業化するための独占提携契約を締結
  • Alvotech与富士制药缔结排他性伙伴关系,在日本从事生物类似物的开发和商业化
  • Dynex Technologies获得CFDA核准,向中国供应AGILITY自动ELISA处理系统
  • Alvotech and Fuji Pharma Enter into Exclusive Partnership for Development and Commercialization of Biosimilars in Japan
  • SANYEI CORPORATION Based in Japan Launches ION-Sei™ into the UK Market in Time for the Christmas Season. A Unique Electric Toothbrush That Uses Patented Technology to Suppress Bacteria That Cause Plaque and Gum Disease